APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lidocaine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lidocaine Injection Industry Growth and Trends Forecast to 2032

2 January 2026104 pages

Choose your research edition.

Industry ResearchLidocaine Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Lidocaine Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Lidocaine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lidocaine Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Lidocaine Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Lidocaine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lidocaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lidocaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lidocaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lidocaine Injection include Actiza Pharmaceutical, AdvaCare Pharma, Amphastar, AuroMedics, Hameln Pharmaceuticals, Hikma, Livealth Biopharma, Fresenius Kabi and Hainan Tianhuang Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lidocaine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lidocaine Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lidocaine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lidocaine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lidocaine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lidocaine Injection Market by Company

Actiza Pharmaceutical

AdvaCare Pharma

Amphastar

AuroMedics

Hameln Pharmaceuticals

Hikma

Livealth Biopharma

Fresenius Kabi

Hainan Tianhuang Pharmacy

Pfizer

JumpCan

LongerPharm Group

Yabao Pharmaceutical

Lidocaine Injection Segment by Type

0.02

0.015

0.01

0.005

Lidocaine Injection Segment by Application

Recovery Center

Hospital

Clinic

Lidocaine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lidocaine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lidocaine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.02 Table 2. Major Company of 0.015 Table 3. Major Company of 0.01 Table 4. Major Company of 0.005 Table 5. Global Lidocaine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 7. Global Lidocaine Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Lidocaine Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Lidocaine Injection Price by Type (2021-2026) & (US$/Unit) Table 11. Global Lidocaine Injection Sales by Type (2027-2032) & (W Units) Table 12. Global Lidocaine Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Lidocaine Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Lidocaine Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Lidocaine Injection Price by Type (2027-2032) & (US$/Unit) Table 16. North America Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 17. North America Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 19. Europe Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 23. Latin America Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Lidocaine Injection Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Lidocaine Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Lidocaine Injection Industry Trends Table 27. Lidocaine Injection Industry Drivers Table 28. Lidocaine Injection Industry Opportunities and Challenges Table 29. Lidocaine Injection Industry Restraints Table 30. Global Lidocaine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Lidocaine Injection Revenue Market Share by Company (2021-2026) Table 32. Global Lidocaine Injection Sales by Company (2021-2026) & (W Units) Table 33. Global Lidocaine Injection Sales Share by Company (2021-2026) Table 34. Global Lidocaine Injection Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Lidocaine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Lidocaine Injection Major Company Production Sites and Headquarters Table 37. Global Lidocaine Injection Company, Product Type & Application Table 38. Global Lidocaine Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Lidocaine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Lidocaine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Lidocaine Injection Sales by Region (2021-2026) & (W Units) Table 43. Global Lidocaine Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Lidocaine Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Lidocaine Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Lidocaine Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Lidocaine Injection Sales by Region (2027-2032) & (W Units) Table 48. Global Lidocaine Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Lidocaine Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Lidocaine Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Lidocaine Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Lidocaine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 54. Global Lidocaine Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Lidocaine Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Lidocaine Injection Price by Application (2021-2026) & (US$/Unit) Table 58. Global Lidocaine Injection Sales by Application (2027-2032) & (W Units) Table 59. Global Lidocaine Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Lidocaine Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Lidocaine Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Lidocaine Injection Price by Application (2027-2032) & (US$/Unit) Table 63. North America Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 64. North America Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 66. Europe Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 70. Latin America Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Lidocaine Injection Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Lidocaine Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Actiza Pharmaceutical Company Information Table 74. Actiza Pharmaceutical Business Overview Table 75. Actiza Pharmaceutical Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Actiza Pharmaceutical Lidocaine Injection Product Portfolio Table 77. Actiza Pharmaceutical Recent Development Table 78. AdvaCare Pharma Company Information Table 79. AdvaCare Pharma Business Overview Table 80. AdvaCare Pharma Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AdvaCare Pharma Lidocaine Injection Product Portfolio Table 82. AdvaCare Pharma Recent Development Table 83. Amphastar Company Information Table 84. Amphastar Business Overview Table 85. Amphastar Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Amphastar Lidocaine Injection Product Portfolio Table 87. Amphastar Recent Development Table 88. AuroMedics Company Information Table 89. AuroMedics Business Overview Table 90. AuroMedics Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AuroMedics Lidocaine Injection Product Portfolio Table 92. AuroMedics Recent Development Table 93. Hameln Pharmaceuticals Company Information Table 94. Hameln Pharmaceuticals Business Overview Table 95. Hameln Pharmaceuticals Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hameln Pharmaceuticals Lidocaine Injection Product Portfolio Table 97. Hameln Pharmaceuticals Recent Development Table 98. Hikma Company Information Table 99. Hikma Business Overview Table 100. Hikma Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hikma Lidocaine Injection Product Portfolio Table 102. Hikma Recent Development Table 103. Livealth Biopharma Company Information Table 104. Livealth Biopharma Business Overview Table 105. Livealth Biopharma Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Livealth Biopharma Lidocaine Injection Product Portfolio Table 107. Livealth Biopharma Recent Development Table 108. Fresenius Kabi Company Information Table 109. Fresenius Kabi Business Overview Table 110. Fresenius Kabi Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Fresenius Kabi Lidocaine Injection Product Portfolio Table 112. Fresenius Kabi Recent Development Table 113. Hainan Tianhuang Pharmacy Company Information Table 114. Hainan Tianhuang Pharmacy Business Overview Table 115. Hainan Tianhuang Pharmacy Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Hainan Tianhuang Pharmacy Lidocaine Injection Product Portfolio Table 117. Hainan Tianhuang Pharmacy Recent Development Table 118. Pfizer Company Information Table 119. Pfizer Business Overview Table 120. Pfizer Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Pfizer Lidocaine Injection Product Portfolio Table 122. Pfizer Recent Development Table 123. JumpCan Company Information Table 124. JumpCan Business Overview Table 125. JumpCan Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. JumpCan Lidocaine Injection Product Portfolio Table 127. JumpCan Recent Development Table 128. LongerPharm Group Company Information Table 129. LongerPharm Group Business Overview Table 130. LongerPharm Group Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. LongerPharm Group Lidocaine Injection Product Portfolio Table 132. LongerPharm Group Recent Development Table 133. Yabao Pharmaceutical Company Information Table 134. Yabao Pharmaceutical Business Overview Table 135. Yabao Pharmaceutical Lidocaine Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Yabao Pharmaceutical Lidocaine Injection Product Portfolio Table 137. Yabao Pharmaceutical Recent Development Table 138. North America Lidocaine Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. North America Lidocaine Injection Sales by Country (2021-2026) & (W Units) Table 140. North America Lidocaine Injection Sales Market Share by Country (2021-2026) Table 141. North America Lidocaine Injection Sales Forecast by Country (2027-2032) & (W Units) Table 142. North America Lidocaine Injection Sales Market Share Forecast by Country (2027-2032) Table 143. North America Lidocaine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Lidocaine Injection Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Lidocaine Injection Market Share by Country (2021-2026) Table 146. North America Lidocaine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Lidocaine Injection Market Share Forecast by Country (2027-2032) Table 148. Europe Lidocaine Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. Europe Lidocaine Injection Sales by Country (2021-2026) & (W Units) Table 150. Europe Lidocaine Injection Sales Market Share by Country (2021-2026) Table 151. Europe Lidocaine Injection Sales Forecast by Country (2027-2032) & (W Units) Table 152. Europe Lidocaine Injection Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Lidocaine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Lidocaine Injection Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Lidocaine Injection Market Share by Country (2021-2026) Table 156. Europe Lidocaine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Lidocaine Injection Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Lidocaine Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Lidocaine Injection Sales by Country (2021-2026) & (W Units) Table 160. Asia-Pacific Lidocaine Injection Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Lidocaine Injection Sales Forecast by Country (2027-2032) & (W Units) Table 162. Asia-Pacific Lidocaine Injection Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Lidocaine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Lidocaine Injection Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Lidocaine Injection Market Share by Country (2021-2026) Table 166. Asia-Pacific Lidocaine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Lidocaine Injection Market Share Forecast by Country (2027-2032) Table 168. Latin America Lidocaine Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 169. Latin America Lidocaine Injection Sales by Country (2021-2026) & (W Units) Table 170. Latin America Lidocaine Injection Sales Market Share by Country (2021-2026) Table 171. Latin America Lidocaine Injection Sales Forecast by Country (2027-2032) & (W Units) Table 172. Latin America Lidocaine Injection Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Lidocaine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Lidocaine Injection Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Lidocaine Injection Market Share by Country (2021-2026) Table 176. Latin America Lidocaine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Lidocaine Injection Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Lidocaine Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Lidocaine Injection Sales by Country (2021-2026) & (W Units) Table 180. Middle East and Africa Lidocaine Injection Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Lidocaine Injection Sales Forecast by Country (2027-2032) & (W Units) Table 182. Middle East and Africa Lidocaine Injection Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Lidocaine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Lidocaine Injection Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Lidocaine Injection Market Share by Country (2021-2026) Table 186. Middle East and Africa Lidocaine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Lidocaine Injection Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Lidocaine Injection Distributors List Table 191. Lidocaine Injection Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Lidocaine Injection Image Figure 2. Global Lidocaine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lidocaine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Lidocaine Injection Sales (2021-2032) & (W Units) Figure 5. 0.02 Image Figure 6. Global 0.02 Sales YoY Growth (2021-2032) & (W Units) Figure 7. 0.015 Image Figure 8. Global 0.015 Sales YoY Growth (2021-2032) & (W Units) Figure 9. 0.01 Image Figure 10. Global 0.01 Sales YoY Growth (2021-2032) & (W Units) Figure 11. 0.005 Image Figure 12. Global 0.005 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Lidocaine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Lidocaine Injection Market Share by Type 2025 VS 2032 Figure 15. North America Lidocaine Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Lidocaine Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Lidocaine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Lidocaine Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Lidocaine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Lidocaine Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Lidocaine Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Lidocaine Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Lidocaine Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Lidocaine Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Lidocaine Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Lidocaine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Lidocaine Injection Market Share by Application 2025 VS 2032 Figure 35. North America Lidocaine Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Lidocaine Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Lidocaine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Lidocaine Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Lidocaine Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Lidocaine Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Lidocaine Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Lidocaine Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Lidocaine Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Lidocaine Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Lidocaine Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Lidocaine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Lidocaine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Lidocaine Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Lidocaine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Lidocaine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Lidocaine Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Lidocaine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Lidocaine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Lidocaine Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Lidocaine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Lidocaine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Lidocaine Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Lidocaine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Lidocaine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lidocaine Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Lidocaine Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.02
  • 0.015
  • 0.01
  • 0.005
Applications
  • Recovery Center
  • Hospital
  • Clinic
Companies covered
  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Amphastar
  • AuroMedics
  • Hameln Pharmaceuticals
  • Hikma
  • Livealth Biopharma
  • Fresenius Kabi
  • Hainan Tianhuang Pharmacy
  • Pfizer
  • JumpCan
  • LongerPharm Group
  • Yabao Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lidocaine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lidocaine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lidocaine Injection Market by Type
  6. 1.3.1 0.02
  7. 1.3.2 0.015
  8. 1.3.3 0.01
  9. 1.3.4 0.005
  10. 1.4 Global Lidocaine Injection Market Size by Type
  11. 1.4.1 Global Lidocaine Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Lidocaine Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Lidocaine Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Lidocaine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Lidocaine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Lidocaine Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Lidocaine Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Lidocaine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lidocaine Injection Industry Trends
  2. 2.2 Lidocaine Injection Industry Drivers
  3. 2.3 Lidocaine Injection Industry Opportunities and Challenges
  4. 2.4 Lidocaine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lidocaine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Lidocaine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Lidocaine Injection Price (2021-2026)
  4. 3.4 Global Lidocaine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lidocaine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Lidocaine Injection Company, Product Type & Application
  7. 3.7 Global Lidocaine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lidocaine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lidocaine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lidocaine Injection Tier 1, Tier 2, and Tier 3
4 Lidocaine Injection Regional Status and Outlook
  1. 4.1 Global Lidocaine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lidocaine Injection Historic Market Size by Region
  3. 4.2.1 Global Lidocaine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lidocaine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lidocaine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lidocaine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Lidocaine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lidocaine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lidocaine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lidocaine Injection by Application
  1. 5.1 Lidocaine Injection Market by Application
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Lidocaine Injection Market Size by Application
  6. 5.2.1 Global Lidocaine Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lidocaine Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lidocaine Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lidocaine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lidocaine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lidocaine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lidocaine Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lidocaine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actiza Pharmaceutical
  2. 6.1.1 Actiza Pharmaceutical Company Information
  3. 6.1.2 Actiza Pharmaceutical Business Overview
  4. 6.1.3 Actiza Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actiza Pharmaceutical Lidocaine Injection Product Portfolio
  6. 6.1.5 Actiza Pharmaceutical Recent Developments
  7. 6.2 AdvaCare Pharma
  8. 6.2.1 AdvaCare Pharma Company Information
  9. 6.2.2 AdvaCare Pharma Business Overview
  10. 6.2.3 AdvaCare Pharma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AdvaCare Pharma Lidocaine Injection Product Portfolio
  12. 6.2.5 AdvaCare Pharma Recent Developments
  13. 6.3 Amphastar
  14. 6.3.1 Amphastar Company Information
  15. 6.3.2 Amphastar Business Overview
  16. 6.3.3 Amphastar Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amphastar Lidocaine Injection Product Portfolio
  18. 6.3.5 Amphastar Recent Developments
  19. 6.4 AuroMedics
  20. 6.4.1 AuroMedics Company Information
  21. 6.4.2 AuroMedics Business Overview
  22. 6.4.3 AuroMedics Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AuroMedics Lidocaine Injection Product Portfolio
  24. 6.4.5 AuroMedics Recent Developments
  25. 6.5 Hameln Pharmaceuticals
  26. 6.5.1 Hameln Pharmaceuticals Company Information
  27. 6.5.2 Hameln Pharmaceuticals Business Overview
  28. 6.5.3 Hameln Pharmaceuticals Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hameln Pharmaceuticals Lidocaine Injection Product Portfolio
  30. 6.5.5 Hameln Pharmaceuticals Recent Developments
  31. 6.6 Hikma
  32. 6.6.1 Hikma Company Information
  33. 6.6.2 Hikma Business Overview
  34. 6.6.3 Hikma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hikma Lidocaine Injection Product Portfolio
  36. 6.6.5 Hikma Recent Developments
  37. 6.7 Livealth Biopharma
  38. 6.7.1 Livealth Biopharma Company Information
  39. 6.7.2 Livealth Biopharma Business Overview
  40. 6.7.3 Livealth Biopharma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Livealth Biopharma Lidocaine Injection Product Portfolio
  42. 6.7.5 Livealth Biopharma Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Lidocaine Injection Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 Hainan Tianhuang Pharmacy
  50. 6.9.1 Hainan Tianhuang Pharmacy Company Information
  51. 6.9.2 Hainan Tianhuang Pharmacy Business Overview
  52. 6.9.3 Hainan Tianhuang Pharmacy Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hainan Tianhuang Pharmacy Lidocaine Injection Product Portfolio
  54. 6.9.5 Hainan Tianhuang Pharmacy Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Lidocaine Injection Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 JumpCan
  62. 6.11.1 JumpCan Company Information
  63. 6.11.2 JumpCan Business Overview
  64. 6.11.3 JumpCan Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 JumpCan Lidocaine Injection Product Portfolio
  66. 6.11.5 JumpCan Recent Developments
  67. 6.12 LongerPharm Group
  68. 6.12.1 LongerPharm Group Company Information
  69. 6.12.2 LongerPharm Group Business Overview
  70. 6.12.3 LongerPharm Group Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 LongerPharm Group Lidocaine Injection Product Portfolio
  72. 6.12.5 LongerPharm Group Recent Developments
  73. 6.13 Yabao Pharmaceutical
  74. 6.13.1 Yabao Pharmaceutical Company Information
  75. 6.13.2 Yabao Pharmaceutical Business Overview
  76. 6.13.3 Yabao Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yabao Pharmaceutical Lidocaine Injection Product Portfolio
  78. 6.13.5 Yabao Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Lidocaine Injection Sales by Country
  2. 7.1.1 North America Lidocaine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lidocaine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Lidocaine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lidocaine Injection Market Size by Country
  6. 7.2.1 North America Lidocaine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lidocaine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Lidocaine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lidocaine Injection Sales by Country
  2. 8.1.1 Europe Lidocaine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lidocaine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Lidocaine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lidocaine Injection Market Size by Country
  6. 8.2.1 Europe Lidocaine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lidocaine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lidocaine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lidocaine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Lidocaine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lidocaine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lidocaine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lidocaine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Lidocaine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lidocaine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lidocaine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lidocaine Injection Sales by Country
  2. 10.1.1 South America Lidocaine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lidocaine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Lidocaine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lidocaine Injection Market Size by Country
  6. 10.2.1 South America Lidocaine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lidocaine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Lidocaine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lidocaine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Lidocaine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lidocaine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lidocaine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lidocaine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Lidocaine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lidocaine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lidocaine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lidocaine Injection Value Chain Analysis
  2. 12.1.1 Lidocaine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lidocaine Injection Production Mode & Process
  7. 12.2 Lidocaine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lidocaine Injection Distributors
  10. 12.2.3 Lidocaine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst